Ekkehard Schütz

Directeur Technique/Scientifique/R&D chez ONCOCYTE CORPORATION

Fortune : - $ au 31/05/2024

Health Technology

Consumer Services

Postes actifs de Ekkehard Schütz

Sociétés	Poste	Début	Fin
ONCOCYTE CORPORATION	Directeur Technique/Scientifique/R&D	01/04/2021	-
Chronix Biomedical, Inc. Chronix Biomedical, Inc. Medical SpecialtiesHealth Technology Chronix Biomedical, Inc. manufactures diagnostic substances chemicals. It develops DNA-based blood tests primarily for monitoring minimal residual disease in cancer patients. The firm also develops a technology that measures personalized biomarkers in cancers of the colorectum, prostate, lung, ovarian, pancreas, blood and central nervous system. The company was founded by Wiiliam A. Boeger and Howard B. Urnovitz in 1997 and is headquartered in San Jose, CA.	Directeur Général	-	-
	Directeur Technique/Scientifique/R&D	-	-
Chronix Biomedical GmbH	Corporate Officer/Principal	01/04/2011	-

University of Gottingen

Doctorate Degree

Internationale

Etats-Unis	3
Allemagne	3

Opérationnelle

Sectorielle

Health Technology	3
Consumer Services	2

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés cotées	1
ONCOCYTE CORPORATION	Health Technology

Entreprise privées	2
Chronix Biomedical, Inc. Chronix Biomedical, Inc. Medical SpecialtiesHealth Technology Chronix Biomedical, Inc. manufactures diagnostic substances chemicals. It develops DNA-based blood tests primarily for monitoring minimal residual disease in cancer patients. The firm also develops a technology that measures personalized biomarkers in cancers of the colorectum, prostate, lung, ovarian, pancreas, blood and central nervous system. The company was founded by Wiiliam A. Boeger and Howard B. Urnovitz in 1997 and is headquartered in San Jose, CA.	Health Technology
Chronix Biomedical GmbH

Entreprise privées

Health Technology

Chronix Biomedical GmbH